Clinical Report: Training the Medicine Makers the UK Can’t Afford to Lose
Overview
The UK faces significant challenges in retaining skilled talent and addressing skills gaps in life sciences, with a notable decline in clinical trials and pharmaceutical investments. Virtual reality (VR) training offers a promising solution to enhance the training of future medicine makers, providing a scalable and cost-effective alternative to traditional methods.
Background
The UK government aims to position the country as a leading life science nation by 2030, yet reports indicate a growing skills gap that threatens this ambition. The decline in clinical trials and pharmaceutical investments highlights the urgent need for innovative training solutions. As the industry forecasts a demand for 145,000 new jobs in the Bio/Pharma sector over the next decade, addressing these gaps is critical for maintaining the UK's competitive edge.
Data Highlights
No numerical data available in the source material.
Key Findings
- 41% decrease in industry clinical trials initiated in the UK from 2017 to 2021.
- UK fell from 4th to 98th in global pharmaceutical trade balance since 2010.
- 52% of engineering graduates in the UK are from overseas.
- VR training allows for repeated practice without the waste of materials, enhancing skill acquisition.
- VR can standardize training across different geographies and class sizes.
- Recent studies show VR improves competence and confidence in clinical skills compared to traditional methods.
Clinical Implications
Healthcare professionals should consider integrating VR technology into training programs to address the skills gap in medicine manufacturing. This approach not only enhances learning efficiency but also reduces costs associated with traditional training methods.
Conclusion
The adoption of VR in training medicine makers represents a strategic response to the pressing skills shortages in the UK life sciences sector, potentially revitalizing the industry and supporting future innovations.
References
- Brain, Understanding the Impact of Bureaucracy on Patient Participation in Research and Clinical Trials, 2023
- Ophthalmology Management, The Economy and Ophthalmology: An Academic Perspective, 2023
- Brain, Advancements in Clinical Research Practices in the United Kingdom, 2023
- European Medicines Agency, Guideline on quality, non-clinical and clinical requirements for investigational advanced therapy medicinal products in clinical trials, 2025
- The ASCO Post — Financial Revamping of Medical Education
- Guideline on quality, non-clinical and clinical requirements for investigational advanced therapy medicinal products in clinical trials - Scientific guideline | European Medicines Agency (EMA)
- Impacts of VR simulation on nursing students' competence, confidence, and satisfaction: A systematic review and meta-analysis of randomised controlled trials - PubMed
- https://cgt.ams3.cdn.digitaloceanspaces.com/CGT-Catapult-Skills-Demand-Report-2025.pdf
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
